The 2019 updated eular/era-edta guidelines for the management of lupus nephritis. Expert comments. part ii
- Kozlovskaya N.L.
- Solovyev S.K.
- Aseeva E.A.
- Popkova T.V.
- Panafidina T.A.
- Nasonov E.L.
- Lila A.M.
- Mesnyankina A.A.
- Nikishina N.Yu.
DOI Publisher
IMA Press, LLCAbstract
The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monitoring, and prognosis for LN, and the management of patients with end-stage renal failure and antiphospholipid syndrome. Attention is paid to the problem of LN and pregnancy, as well as to the management of pediatric patients with kidney damage. © 2021, Ima-Press Publishing House. All rights reserved
Add to ORKG